Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "Cutaneous sclerosis"
Show Display Options
Rank Status Study
1 Completed
Has Results
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease;   Systemic Scleroderma
Interventions: Drug: imatinib mesylate;   Biological: rituximab
2 Completed Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Conditions: Graft vs Host Disease;   Cutaneous Sclerosis;   Bronchiolitis Obliterans
Intervention:

Study has passed its completion date and status has not been verified in more than two years.